ARNA
Arena Pharmaceuticals Inc
Price:  
99.99 
USD
Volume:  
5,621,235.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ARNA WACC - Weighted Average Cost of Capital

The WACC of Arena Pharmaceuticals Inc (ARNA) is 7.1%.

The Cost of Equity of Arena Pharmaceuticals Inc (ARNA) is 7.15%.
The Cost of Debt of Arena Pharmaceuticals Inc (ARNA) is 8.05%.

Range Selected
Cost of equity 6.00% - 8.30% 7.15%
Tax rate 27.00% - 27.00% 27.00%
Cost of debt 7.00% - 9.10% 8.05%
WACC 5.9% - 8.3% 7.1%
WACC

ARNA WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 4.2% 5.2%
Adjusted beta 0.66 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.30%
Tax rate 27.00% 27.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 9.10%
After-tax WACC 5.9% 8.3%
Selected WACC 7.1%